Elixir Medical Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 105

Employees

  • Latest Deal Type
  • Series G

  • Latest Deal Amount
  • $38.5M

  • Investors
  • 1

Elixir Medical General Information

Description

Developer of a bioadaptor designed to restore natural artery function and improve patient outcomes in vascular interventions. The company offers a unique implant that uncages the artery, allowing it to return to its natural physiology, enabling healthcare professionals to provide more effective treatments for coronary artery disease and complex lesions, leading to better clinical results.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 920 North McCarthy Boulevard
  • Milpitas, CA 95035
  • United States
+1 (408)
Primary Industry
Surgical Devices
Corporate Office
  • 920 North McCarthy Boulevard
  • Milpitas, CA 95035
  • United States
+1 (408)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Elixir Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series G) 05-Apr-2019 $38.5M Completed Generating Revenue
6. Later Stage VC (Series F) 14-May-2017 Completed Generating Revenue
5. Later Stage VC (Series E) 01-Jan-2013 Completed Generating Revenue
4. Later Stage VC (Series D) 28-Sep-2011 Completed Generating Revenue
3. Later Stage VC (Series C) 02-Sep-2009 Completed Generating Revenue
2. Early Stage VC (Series B) 13-Dec-2007 $21M $26.3M Completed Generating Revenue
1. Early Stage VC (Series A) 18-Mar-2005 $5.3M $5.3M Completed Startup
To view Elixir Medical’s complete valuation and funding history, request access »

Elixir Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series G
Series F
Series E
Series D
Series C
Series B 20,987,000 $0.001000 $0.08 $1 $1 1x $1 15.46%
Series A 13,300,000 $0.001000 $0.03 $0.4 $0.4 1x $0.4 9.8%
To view Elixir Medical’s complete cap table history, request access »

Elixir Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a bioadaptor designed to restore natural artery function and improve patient outcomes in vascular intervent
Surgical Devices
Milpitas, CA
105 As of 2025

Wayne, PA
 

Santa Clara, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Elixir Medical Competitors (23)

One of Elixir Medical’s 23 competitors is Vesper Medical, a Formerly VC-backed company based in Wayne, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vesper Medical Formerly VC-backed Wayne, PA
ShockWave Medical Formerly VC-backed Santa Clara, CA
Endospan Formerly VC-backed Herzliya, Israel
Spine Wave Venture Capital-Backed Shelton, CT
FLEX Vascular Venture Capital-Backed Plymouth, MN
You’re viewing 5 of 23 competitors. Get the full list »

Elixir Medical Patents

Elixir Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024254268-A2 Aspiration catheter systems Inactive 08-Jun-2023
WO-2024254268-A3 Aspiration catheter systems Inactive 08-Jun-2023
EP-4712962-A1 Anticoagulant compositions comprising anti-platelet and anti-inflammatory drugs and methods and devices for their use Pending 16-May-2023
US-20260315653-A1 Anticoagulant compositions comprising anti-platelet and anti-inflammatory drugs and methods and devices for their use Pending 16-May-2023
WO-2024238703-A1 Anticoagulant compositions comprising anti-platelet and anti-inflammatory drugs and methods and devices for their use Inactive 16-May-2023 A61K31/4545
To view Elixir Medical’s complete patent history, request access »

Elixir Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Elixir Medical Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Invus (Private Equity) PE/Buyout Minority
To view Elixir Medical’s complete investors history, request access »

Elixir Medical FAQs

  • When was Elixir Medical founded?

    Elixir Medical was founded in 2005.

  • Where is Elixir Medical headquartered?

    Elixir Medical is headquartered in Milpitas, CA.

  • What is the size of Elixir Medical?

    Elixir Medical has 105 total employees.

  • What industry is Elixir Medical in?

    Elixir Medical’s primary industry is Surgical Devices.

  • Is Elixir Medical a private or public company?

    Elixir Medical is a Private company.

  • What is the current valuation of Elixir Medical?

    The current valuation of Elixir Medical is .

  • What is Elixir Medical’s current revenue?

    The current revenue for Elixir Medical is .

  • How much funding has Elixir Medical raised over time?

    Elixir Medical has raised $171M.

  • Who are Elixir Medical’s investors?

    Invus (Private Equity) has invested in Elixir Medical.

  • Who are Elixir Medical’s competitors?

    Vesper Medical, ShockWave Medical, Endospan, Spine Wave, and FLEX Vascular are some of the 23 competitors of Elixir Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process